Physician's Weekly

JULY 1, 2025

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than 15,000 participants, including clinicians, academicians, allied health professionals, and others interested in diabetes. ” The study was funded by MannKind, the manufacturer of Afrezza. .

Diabetes 52

Diabetes Patient-Centered Management Individual 52

The Medical Futurist

JUNE 21, 2025

However, things are moving fast, and success doesn’t come easy for the pioneers of any medical field. Scientists at Columbia University Medical Center and the University of Iowa used CRISPR to repair a genetic mutation responsible for retinitis pigmentosa in induced pluripotent stem cells derived from a patient with the disease.

Diabetes 105

Diabetes Patient-Centered IT Patients 105

Plum Health

AUGUST 30, 2024

Mike to discuss affordable GLP-1 medication! Managing diabetes—especially as you get older—can be challenging physically, emotionally, and financially. If you’re living with Type 2 diabetes, you’ve probably heard of Ozempic, Wegovy (semaglutide), Mounjaro or Zepbound (tirzepatide). Is Ozempic (Semaglutide) Covered By Insurance?

Primary Care 52

Primary Care Insurance Diabetes Manufacturing 52

GeriPal

JUNE 20, 2024

Accreditation In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IT 120

IT Patient-Centered Patients Clinic 120

GeriPal

MAY 5, 2022

I’d been working with persons who had diabetes and also caregivers and so forth, trying to go at the direction and realize as I look more and more at hearing loss, that it was totally unrecognized in clinical practice. And he liked some of what I was doing, which was really on diabetes and hearing loss. Five big manufacturers.

IT 102

IT Screening Hospital Clinic 102

FDA Law

SEPTEMBER 8, 2022

Recognizing the problems that high prescription drug costs pose to patient access to medications, many drug manufacturers have created copay assistance programs to help patients afford the copays and deductibles for their medications. These prohibitions are often referred to as copay accumulator adjustment programs.

Insurance 83

Insurance Patients Manufacturing Patient-Centered 83